230 related articles for article (PubMed ID: 16308692)
1. T1 and T2 relaxivity of intracellular and extracellular USPIO at 1.5T and 3T clinical MR scanning.
Simon GH; Bauer J; Saborovski O; Fu Y; Corot C; Wendland MF; Daldrup-Link HE
Eur Radiol; 2006 Mar; 16(3):738-45. PubMed ID: 16308692
[TBL] [Abstract][Full Text] [Related]
2. Ultrasmall superparamagnetic iron-oxide-enhanced MR imaging of normal bone marrow in rodents: original research original research.
Simon GH; Raatschen HJ; Wendland MF; von Vopelius-Feldt J; Fu Y; Chen MH; Daldrup-Link HE
Acad Radiol; 2005 Sep; 12(9):1190-7. PubMed ID: 16099684
[TBL] [Abstract][Full Text] [Related]
3. Comparison of two superparamagnetic viral-sized iron oxide particles ferumoxides and ferumoxtran-10 with a gadolinium chelate in imaging intracranial tumors.
Varallyay P; Nesbit G; Muldoon LL; Nixon RR; Delashaw J; Cohen JI; Petrillo A; Rink D; Neuwelt EA
AJNR Am J Neuroradiol; 2002 Apr; 23(4):510-9. PubMed ID: 11950637
[TBL] [Abstract][Full Text] [Related]
4. Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro.
Metz S; Bonaterra G; Rudelius M; Settles M; Rummeny EJ; Daldrup-Link HE
Eur Radiol; 2004 Oct; 14(10):1851-8. PubMed ID: 15249981
[TBL] [Abstract][Full Text] [Related]
5. Splenic imaging with ultrasmall superparamagnetic iron oxide ferumoxtran-10 (AMI-7227): preliminary observations.
Harisinghani MG; Saini S; Weissleder R; Rubin D; deLange E; Harms S; Weinreb J; Small W; Sukerkar A; Brown JJ; Zelch J; Lucas M; Morris M; Hahn PF
J Comput Assist Tomogr; 2001; 25(5):770-6. PubMed ID: 11584239
[TBL] [Abstract][Full Text] [Related]
6. The pharmacokinetics of the lymphotropic nanoparticle MRI contrast agent ferumoxtran-10.
Islam T; Wolf G
Cancer Biomark; 2009; 5(2):69-73. PubMed ID: 19414923
[TBL] [Abstract][Full Text] [Related]
7. Differential uptake of ferumoxtran-10 and ferumoxytol, ultrasmall superparamagnetic iron oxide contrast agents in rabbit: critical determinants of atherosclerotic plaque labeling.
Yancy AD; Olzinski AR; Hu TC; Lenhard SC; Aravindhan K; Gruver SM; Jacobs PM; Willette RN; Jucker BM
J Magn Reson Imaging; 2005 Apr; 21(4):432-42. PubMed ID: 15779033
[TBL] [Abstract][Full Text] [Related]
8. Imaging of macrophages in soft-tissue infection in rats: relationship between ultrasmall superparamagnetic iron oxide dose and MR signal characteristics.
Lutz AM; Weishaupt D; Persohn E; Goepfert K; Froehlich J; Sasse B; Gottschalk J; Marincek B; Kaim AH
Radiology; 2005 Mar; 234(3):765-75. PubMed ID: 15665219
[TBL] [Abstract][Full Text] [Related]
9. Multicentre dose-ranging study on the efficacy of USPIO ferumoxtran-10 for liver MR imaging.
Saini S; Sharma R; Baron RL; Turner DA; Ros PR; Hahn PF; Small WC; Delange EE; Stillman AE; Edelman RR; Runge VM; Outwater EK
Clin Radiol; 2000 Sep; 55(9):690-5. PubMed ID: 10988047
[TBL] [Abstract][Full Text] [Related]
10. USPIO (Ferumoxtran-10)-enhanced MRI to visualize reticuloendothelial system cells in neonatal rats: feasibility and biodistribution study.
Azoulay R; Olivier P; Baud O; Verney C; Santus R; Robert P; Gressens P; Sebag G
J Magn Reson Imaging; 2008 Oct; 28(4):1046-52. PubMed ID: 18821607
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of tumoral enhancement by superparamagnetic iron oxide particles: comparative studies with ferumoxtran and anionic iron oxide nanoparticles.
Brillet PY; Gazeau F; Luciani A; Bessoud B; Cuénod CA; Siauve N; Pons JN; Poupon J; Clément O
Eur Radiol; 2005 Jul; 15(7):1369-77. PubMed ID: 15726379
[TBL] [Abstract][Full Text] [Related]
12. Ultrasmall supraparamagnetic iron oxide-enhanced magnetic resonance imaging of antigen-induced arthritis: a comparative study between SHU 555 C, ferumoxtran-10, and ferumoxytol.
Simon GH; von Vopelius-Feldt J; Fu Y; Schlegel J; Pinotek G; Wendland MF; Chen MH; Daldrup-Link HE
Invest Radiol; 2006 Jan; 41(1):45-51. PubMed ID: 16355039
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of superparamagnetic iron oxide for MR imaging of liver injury: proton relaxation mechanisms and optimal MR imaging parameters.
Tanimoto A; Mukai M; Kuribayashi S
Magn Reson Med Sci; 2006 Jul; 5(2):89-98. PubMed ID: 17008765
[TBL] [Abstract][Full Text] [Related]
14. Real-time imaging of convection-enhanced delivery of viruses and virus-sized particles.
Szerlip NJ; Walbridge S; Yang L; Morrison PF; Degen JW; Jarrell ST; Kouri J; Kerr PB; Kotin R; Oldfield EH; Lonser RR
J Neurosurg; 2007 Sep; 107(3):560-7. PubMed ID: 17886556
[TBL] [Abstract][Full Text] [Related]
15. Physical and biological characterization of superparamagnetic iron oxide- and ultrasmall superparamagnetic iron oxide-labeled cells: a comparison.
Sun R; Dittrich J; Le-Huu M; Mueller MM; Bedke J; Kartenbeck J; Lehmann WD; Krueger R; Bock M; Huss R; Seliger C; Gröne HJ; Misselwitz B; Semmler W; Kiessling F
Invest Radiol; 2005 Aug; 40(8):504-13. PubMed ID: 16024988
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance imaging of experimental atherosclerotic plaque: comparison of two ultrasmall superparamagnetic particles of iron oxide.
Herborn CU; Vogt FM; Lauenstein TC; Dirsch O; Corot C; Robert P; Ruehm SG
J Magn Reson Imaging; 2006 Aug; 24(2):388-93. PubMed ID: 16791857
[TBL] [Abstract][Full Text] [Related]
17. Atorvastatin and uptake of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) in human monocyte-macrophages: implications for magnetic resonance imaging.
Müller K; Skepper JN; Tang TY; Graves MJ; Patterson AJ; Corot C; Lancelot E; Thompson PW; Brown AP; Gillard JH
Biomaterials; 2008 Jun; 29(17):2656-62. PubMed ID: 18377983
[TBL] [Abstract][Full Text] [Related]
18. Biodistribution of ultrasmall iron oxide particles in the rat liver.
Van Beers BE; Sempoux C; Materne R; Delos M; Smith AM
J Magn Reson Imaging; 2001 Apr; 13(4):594-9. PubMed ID: 11276104
[TBL] [Abstract][Full Text] [Related]
19. Detection of synovial macrophages in an experimental rabbit model of antigen-induced arthritis: ultrasmall superparamagnetic iron oxide-enhanced MR imaging.
Lutz AM; Seemayer C; Corot C; Gay RE; Goepfert K; Michel BA; Marincek B; Gay S; Weishaupt D
Radiology; 2004 Oct; 233(1):149-57. PubMed ID: 15333767
[TBL] [Abstract][Full Text] [Related]
20. Relaxation effects of ferucarbotran-labeled mesenchymal stem cells at 1.5T and 3T: discrimination of viable from lysed cells.
Henning TD; Wendland MF; Golovko D; Sutton EJ; Sennino B; Malek F; Bauer JS; McDonald DM; Daldrup-Link H
Magn Reson Med; 2009 Aug; 62(2):325-32. PubMed ID: 19353670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
